Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypercholesterolemia: HELP
Frederick J. Raal
Based on 11 articles published since 2007
||||
Expertise Level
The expertise of Frederick J. Raal ranks in the
  • Top 0.19%
  • ... of 29,430 published authors worldwide on Hypercholesterolemia
  • ... from 2007 through 2018
  • ... based on contributions to 11 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Raal, Frederick J   ·   Raal, F   ·   Raal, Frederick
Work Locations
Details
Most likely:    University of the Witwatersrand      
2017
  • Department of Medicine, ECOGENE-21 Clinical and Translational Research Center and Lipidology Unit, Université de Montréal, Chicoutimi, Quebec, Canada. Electronic address: · Lipid Disorders Clinic, Centre for Cardiovascular Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia. · University of Iowa, Iowa City, Iowa. · Biostatistics and Programming, Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · Sanofi, Bridgewater, New Jersey. · Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa. · Pubmed 27793396
2015
  • Lipid Clinic Heart Institute (InCor), University of São Paulo Medical School Hospital, São Paulo, São Paulo, Brazil. Electronic address: · Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. · Genzyme Corporation, Cambridge, MA, USA. · Lipoprotein and Metabolic Disorders Institute, Raleigh, NC, USA; Hypertension and Vascular Disease Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA. · Pubmed 25911076
2011
  • Department of Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa. · Pubmed 21922121
2007
  • Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa. · Pubmed 17985033
2016
  • From the Inra UMR 1280, Université de Nantes, Faculté de Médecine, Nantes, France (A.T., M.P., S.P.-F., A.G., M.C., G.L.); Department of Vascular Medicine, Academic Medical Centre, Amsterdam, The Netherlands (B.S., G.D.-T., J.P., K.H.); Lipidology Division of Internal Medicine, University of Cape Town, Cape Town, South Africa (D.B.); Dipartimiento di Nefrologia Dialisi e Trapianto, SS Annunziata Hospital, Sassari, Italy (M.C., M.C.); University of Palermo, School of Medicine, Palermo, Italy (A.B.C., M.A.); University of Genoa, Genoa, Italy (L.P.); Lipid Clinic Heart Institute (InCor) University of Sao Paulo Medica School Hospital, Sao Paulo, Brazil (R.D.S.); Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa (F.R.); Dipartimento di Medicina Interna, Brotzu Hospital, Cagliari, Italy (P.P.); Inserm UMR 1188, Sainte Clotilde, France (G.L.); Université de la Réunion, Faculté de Médecine, Saint Denis de la Réunion, France (G.L.); and CHU de la Réunion, Saint-Denis de la Réunion, France (G.L.). · Pubmed 27079874
2015
  • From the Department of Medicine, Robarts Research Institute, Schulich School of Medicine, Western University, London, Ontario, Canada (R.A.H.); Nemours Cardiac Center, A. I. duPont Hospital for Children, Wilmington, DE (S.S.G.); Irving Institute for Clinical and Translational Research, Department of Medicine, Columbia University, New York, NY (H.N.G.); Department of Medicine and Biochemistry, Atherogenomics Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada (R.M.); Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa (F.J.R); Department of Genetics (D.J.R.) and Division of Translational Medicine and Human Genetics, Department of Medicine (D.J.R.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Department of Epidemiology and Medicine, University of Iowa, Iowa City (J.G.R.); and Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (F.K.W.). · From the Department of Medicine, Robarts Research Institute, Schulich School of Medicine, Western University, London, Ontario, Canada (R.A.H.); Nemours Cardiac Center, A. I. duPont Hospital for Children, Wilmington, DE (S.S.G.); Irving Institute for Clinical and Translational Research, Department of Medicine, Columbia University, New York, NY (H.N.G.); Department of Medicine and Biochemistry, Atherogenomics Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada (R.M.); Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa (F.J.R); Department of Genetics (D.J.R.) and Division of Translational Medicine and Human Genetics, Department of Medicine (D.J.R.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Department of Epidemiology and Medicine, University of Iowa, Iowa City (J.G.R.); and Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (F.K.W.). · Pubmed 26376908
  • From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and the Department of Medicine, Harvard Medical School, Boston (M.S.S., R.P.G., S.D.W.); the Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg (F.J.R.), and the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town (D.J.B.) - both in South Africa; the Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa City (J.R.); the Sections of Cardiovascular Research and Cardiology, Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.); Amgen, Thousand Oaks, CA (R. Somaratne, J.L., S.M.W., R. Scott); Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.); and the Metabolic and Atherosclerosis Research Center, Cincinnati (E.A.S.). · Pubmed 25773607
  • From the University of Iowa, Iowa City (J.G.R.); Point Médical, Dijon (M.F.), Centre Hospitalier Universitaire de Nantes-Hôpital Nord Laennec, Saint-Herblain (M.K.), University Hospital of Lille, Lille (G. Luc), and Sanofi, Chilly-Mazarin (C.L.) - all in France; Clinique des Maladies Lipidiques de Québec, Quebec, QC, Canada (J.B.); Università di Palermo-Policlinico P. Giaccone, Palermo, Italy (M.A.); the Department of Vascular Medicine, Academic Medical Center, Amsterdam (E.S.S., J.J.P.K.); Lipid Clinic, Oslo University Hospital, Oslo (G. Langslet); University of the Witwatersrand, Johannesburg (F.J.R.); Cardiovascular Center of Sarasota, Sarasota (M.E.S.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Westside Medical Associates of Los Angeles, Beverly Hills, CA (N.E.L.); Regeneron Pharmaceuticals, Tarrytown, NY (R.P.); and Sanofi, Bridgewater, NJ (U.C.). · Pubmed 25773378
2014
  • Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.); TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (R.P.G., M.S.S.); Carbohydrate and Lipid Metabolism Research Unit, Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (F.J.R.); Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, Australia (D.S.); Bethesda Health Research Center, Bethesda, MD (M.B.); Lipid Clinic, Oslo University Hospital, Oslo, Norway (G.L.); Hospital Universitario Miguel Servet, Zaragoza, Spain (F.C.); and Amgen Inc, Thousand Oaks, CA (R.S., P.N., T.L., R.S., S.M.W.). · Pubmed 24255061
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 11 total) written by Frederick J. Raal about Hypercholesterolemia:

  • Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program). 2017
  • Proprotein Convertase Subtilisin Kexin Type 9 Inhibition for Autosomal Recessive Hypercholesterolemia-Brief Report. 2016
  • Suboptimal Control of Lipid Levels: Results from 29 Countries Participating in the Centralized Pan-Regional Surveys on the Undertreatment of Hypercholesterolaemia (CEPHEUS). 2016
  • Nonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB Council. 2015
  • Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia. 2015
  • Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. 2015
  • Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. 2015
  • Reduction of low-density lipoprotein cholesterol by monoclonal antibody inhibition of PCSK9. 2014
  • Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial. 2014
  • CEPHEUS SA: a South African survey on the undertreatment of hypercholesterolaemia. 2011
Show List of Full Article Records
Google Searches

Learn more about Frederick J. Raal using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of the Witwatersrand
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of the Witwatersrand
2017
  • Department of Medicine, ECOGENE-21 Clinical and Translational Research Center and Lipidology Unit, Université de Montréal, Chicoutimi, Quebec, Canada. Electronic address: · Lipid Disorders Clinic, Centre for Cardiovascular Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia. · University of Iowa, Iowa City, Iowa. · Biostatistics and Programming, Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · Sanofi, Bridgewater, New Jersey. · Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa. · Pubmed 27793396
2015
  • Lipid Clinic Heart Institute (InCor), University of São Paulo Medical School Hospital, São Paulo, São Paulo, Brazil. Electronic address: · Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. · Genzyme Corporation, Cambridge, MA, USA. · Lipoprotein and Metabolic Disorders Institute, Raleigh, NC, USA; Hypertension and Vascular Disease Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA. · Pubmed 25911076
2011
  • Department of Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa. · Pubmed 21922121
2007
  • Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa. · Pubmed 17985033
2016
  • From the Inra UMR 1280, Université de Nantes, Faculté de Médecine, Nantes, France (A.T., M.P., S.P.-F., A.G., M.C., G.L.); Department of Vascular Medicine, Academic Medical Centre, Amsterdam, The Netherlands (B.S., G.D.-T., J.P., K.H.); Lipidology Division of Internal Medicine, University of Cape Town, Cape Town, South Africa (D.B.); Dipartimiento di Nefrologia Dialisi e Trapianto, SS Annunziata Hospital, Sassari, Italy (M.C., M.C.); University of Palermo, School of Medicine, Palermo, Italy (A.B.C., M.A.); University of Genoa, Genoa, Italy (L.P.); Lipid Clinic Heart Institute (InCor) University of Sao Paulo Medica School Hospital, Sao Paulo, Brazil (R.D.S.); Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa (F.R.); Dipartimento di Medicina Interna, Brotzu Hospital, Cagliari, Italy (P.P.); Inserm UMR 1188, Sainte Clotilde, France (G.L.); Université de la Réunion, Faculté de Médecine, Saint Denis de la Réunion, France (G.L.); and CHU de la Réunion, Saint-Denis de la Réunion, France (G.L.). · Pubmed 27079874
2015
  • From the Department of Medicine, Robarts Research Institute, Schulich School of Medicine, Western University, London, Ontario, Canada (R.A.H.); Nemours Cardiac Center, A. I. duPont Hospital for Children, Wilmington, DE (S.S.G.); Irving Institute for Clinical and Translational Research, Department of Medicine, Columbia University, New York, NY (H.N.G.); Department of Medicine and Biochemistry, Atherogenomics Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada (R.M.); Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa (F.J.R); Department of Genetics (D.J.R.) and Division of Translational Medicine and Human Genetics, Department of Medicine (D.J.R.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Department of Epidemiology and Medicine, University of Iowa, Iowa City (J.G.R.); and Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (F.K.W.). · From the Department of Medicine, Robarts Research Institute, Schulich School of Medicine, Western University, London, Ontario, Canada (R.A.H.); Nemours Cardiac Center, A. I. duPont Hospital for Children, Wilmington, DE (S.S.G.); Irving Institute for Clinical and Translational Research, Department of Medicine, Columbia University, New York, NY (H.N.G.); Department of Medicine and Biochemistry, Atherogenomics Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada (R.M.); Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa (F.J.R); Department of Genetics (D.J.R.) and Division of Translational Medicine and Human Genetics, Department of Medicine (D.J.R.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Department of Epidemiology and Medicine, University of Iowa, Iowa City (J.G.R.); and Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (F.K.W.). · Pubmed 26376908
  • From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and the Department of Medicine, Harvard Medical School, Boston (M.S.S., R.P.G., S.D.W.); the Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg (F.J.R.), and the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town (D.J.B.) - both in South Africa; the Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa City (J.R.); the Sections of Cardiovascular Research and Cardiology, Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.); Amgen, Thousand Oaks, CA (R. Somaratne, J.L., S.M.W., R. Scott); Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.); and the Metabolic and Atherosclerosis Research Center, Cincinnati (E.A.S.). · Pubmed 25773607
  • From the University of Iowa, Iowa City (J.G.R.); Point Médical, Dijon (M.F.), Centre Hospitalier Universitaire de Nantes-Hôpital Nord Laennec, Saint-Herblain (M.K.), University Hospital of Lille, Lille (G. Luc), and Sanofi, Chilly-Mazarin (C.L.) - all in France; Clinique des Maladies Lipidiques de Québec, Quebec, QC, Canada (J.B.); Università di Palermo-Policlinico P. Giaccone, Palermo, Italy (M.A.); the Department of Vascular Medicine, Academic Medical Center, Amsterdam (E.S.S., J.J.P.K.); Lipid Clinic, Oslo University Hospital, Oslo (G. Langslet); University of the Witwatersrand, Johannesburg (F.J.R.); Cardiovascular Center of Sarasota, Sarasota (M.E.S.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Westside Medical Associates of Los Angeles, Beverly Hills, CA (N.E.L.); Regeneron Pharmaceuticals, Tarrytown, NY (R.P.); and Sanofi, Bridgewater, NJ (U.C.). · Pubmed 25773378
2014
  • Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.); TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (R.P.G., M.S.S.); Carbohydrate and Lipid Metabolism Research Unit, Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (F.J.R.); Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, Australia (D.S.); Bethesda Health Research Center, Bethesda, MD (M.B.); Lipid Clinic, Oslo University Hospital, Oslo, Norway (G.L.); Hospital Universitario Miguel Servet, Zaragoza, Spain (F.C.); and Amgen Inc, Thousand Oaks, CA (R.S., P.N., T.L., R.S., S.M.W.). · Pubmed 24255061
25 Other Locations Show
Yearly article counts 012420010001
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.